2.01 (-%)
As of Dec 06, 2024
Source:
Hillevax, Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines.
| Country | United States |
| Headquarters | boston, massachusetts |
| Phone Number | ( 617 ) 213-5054 |
| Industry | manufacturing |
| CEO | Robert Hershberg |
| Website | www.hillevax.com |